KHI Board of Directors and Federal Liaisons
Chair
- Uptal D. Patel, MD (2023)
FDA Point of Contact
- Kristen Miller, PharmD (2023)
Members
- Jorge Cerda, MD, MS, FASN (2024)
- Bruce F. Culleton, MD (2024)
- Manisha Dadhania, MBA (2024)
- Vanessa A. Evans (2024)
- Jennifer E. Flythe, MD, MPH, FASN (2024)
- Kevin John Fowler (2023)
- Barbara S. Gillespie, MD, FASN (2024)
- Amanda Grandinetti, MPH (2024)
- Nicolas Jose Guzman, MD (2023)
- Meg Jardine, MBBS, PhD (2023)
- Annamaria T. Kausz, MD, MS (2024)
- Jeffrey Lawson, MD, PhD (2024)
- Vandana Dua Niyyar, MD, FASN (2024)
- Thomas D. Nolin, PharmD, PhD, FASN (2024)
- Ikenna Okezie, MD, MBA (2023)
- Meda E. Pavkov, MD, PhD (2023)
- Glenda V. Roberts (2024)
- Bruce M. Robinson, MD, MS, FASN (2024)
- Alain Romero, PharmD, PhD (2023)
- Brigitte Schiller, MD, FASN (2024)
- Amit Sharma, MD, FASN (2024)
- Robert A. Star, MD (2023)
- Howard Trachtman, MD, FASN (2024)
- Amy Young (2023)
FDA Liaisons
- Frank P. Hurst, MD, FASN (2023)
- James P. Smith, MD, MS (2023)
- Aliza M. Thompson, MD, MS (2023)
- Celia Witten, MD, PhD (2023)
Council Liaison
- Linda F. Fried, MD, MPH, FASN (2024)
Disclosures as of September 2021 can be found here.